# Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients

> **NCT04359303** · PHASE3 · UNKNOWN · sponsor: **Javier Hidalgo Tallón** · enrollment: 50 (estimated)

## Conditions studied

- COVID

## Interventions

- **OTHER:** Systemic indirect endovenous ozone therapy

## Key facts

- **NCT ID:** NCT04359303
- **Lead sponsor:** Javier Hidalgo Tallón
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07
- **Primary completion:** 2020-11
- **Final completion:** 2020-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04359303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04359303, "Indirect Endovenous Systemic Ozone for New Coronavirus Disease (COVID19) in Non-intubated Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04359303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*